We found that single-agent treatment and combination treatment significantly inhibited tumor growth, and the combination treatment exhibited the strongest inhibition of tumor growth in the MC38 (Figures 2A, C) and CT26 (Figures 2B, D) allograft tumor models. The gene discussed is DDX53; the disease is neoplasm.